B cell infection and activation by rabies virus-based vaccines

Journal of Virology

Volumn 87, Issue 16, 2013, Pages 9097-9110

  Lytle, Andrew G ^a   Norton, James E ^a   Dorfmeier, Corin L ^a   Shen, Shixue ^a   McGettigan, James P ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD69 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; VIRUS VACCINE; VIRUS VECTOR;

AGED; ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES VIRUS; RHABDOVIRUS INFECTION; UPREGULATION; VACCINATION; VACCINE PRODUCTION; VIRUS REPLICATION;

MURINAE; MUS; RABIES VIRUS;

EID: 84881251071     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00800-13     Document Type: Article

References (67)

1. Dietzschold B, Rupprecht CE, Fu ZF, Koprowski H. 1996. Rhabdoviruses, p 1137-1152. In Fields BN (ed), Fields virology. Lippincott-Raven Publishers, Philadelphia, PA.
2. WHO. 2013. WHO rabies fact sheet no. 99. WHO, Geneva, Switzerland.
3. Plotkin SA. 2008. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47:401-409.
4. Turner GS. 1978. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J. Gen. Virol. 40:595-604.
5. WHO. 1997. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. WHO, Geneva, Switzerland.
6. Moore SM, Hanlon CA. 2010. Rabies-specific antibodies: measuring surrogates of protection against a fatal disease. PLoS Negl. Trop. Dis. 4:e595. doi:10.1371/journal.pntd.0000595.
7. WHO. 2010. WHO recommendations for active rabies immunization after exposure where rabies vaccines are in short supply. WHO, Geneva, Switzerland.
8. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levis R, Meltzer MI, Schaffner W, Cieslak PR, Centers for Disease Control and Prevention. 2010. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm. Rep. 59:1-9.
9. McGettigan JP. 2010. Experimental rabies vaccines for humans. Expert Rev. Vaccines 9:1177-1186.
10. Cenna J, Hunter M, Tan GS, Papaneri AB, Ribka EP, Schnell MJ, Marx PA, McGettigan JP. 2009. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. J. Infect. Dis. 200:1251-1260.
11. Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP. 2008. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine 26:6405-6414.
12. Mebatsion T, Weiland F, Conzelmann KK. 1999. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 73:242-250.
13. Dorfmeier CL, Lytle AG, Dunkel AL, Gatt A, McGettigan JP. 2012. Protective vaccine-induced CD4+ T cell-independent B cell responses against rabies Infection. J. Virol. 86:11533-11540.
14. Jackson AC. 2008. Rabies. Neurol. Clin. 26:717-726.
15. Turner GS. 1976. Thymus dependence of rabies vaccine. J. Gen. Virol. 33:535-538.
16. Mifune K, Takeuchi E, Napiorkowski PA, Yamada A, Sakamoto K. 1981. Essential role of T cells in the postexposure prophylaxis of rabies in mice. Microbiol. Immunol. 25:895-904.
17. Bunschoten H, Dietzschold B, Claassen I, Klapmuts R, Uytdehaag F, Osterhaus A. 1990. Rabies virus cross-reactive murine T cell clones: analysis of helper and delayed-type hypersensitivity function. Viral Immunol. 3:41-53.
18. Perry LL, Lodmell DL. 1991. Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J. Virol. 65:3429-3434.
19. Dorfmeier CL, Tzvetkov EP, Gatt A, McGettigan JP. 2013. Investigating the role for IL-21 in rabies virus vaccine-induced immunity. PLoS Negl. Trop. Dis. 3:e2129. doi:10.1371/journal.pntd.0002129.
20. Thoulouze MI, Lafage M, Montano-Hirose JA, Lafon M. 1997. Rabies virus infects mouse and human lymphocytes and induces apoptosis. J. Virol. 71:7372-7380.
21. Wanjalla CN, Faul EJ, Gomme EA, Schnell MJ. 2010. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity. Vaccine 29:130-140.
22. Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 6:e1001016. doi:10.1371/journal.ppat .1001016.
23. Li J, McGettigan JP, Faber M, Schnell MJ, Dietzschold B. 2008. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway. Vaccine 26:419-426.
24. Ray NB, Ewalt LC, Lodmell DL. 1995. Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence. J. Virol. 69:764-772.
25. Rodriguez-Pinto D, Moreno J. 2005. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur. J. Immunol. 35:1097-1105.
26. Rodriguez-Pinto D. 2005. B cells as antigen presenting cells. Cell. Immunol. 238:67-75.
27. Hon H, Oran A, Brocker T, Jacob J. 2005. B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J. Immunol. 174:5233-5242.
28. Pone EJ, Zan H, Zhang J, Al-Qahtani A, Xu Z, Casali P. 2010. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin classswitch DNA recombination: relevance to microbial antibody responses. Crit. Rev. Immunol. 30:1-29.
29. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27:2366-2374.
30. Lee BO, Moyron-Quiroz J, Rangel-Moreno J, Kusser KL, Hartson L, Sprague F, Lund FE, Randall TD. 2003. CD40, but not CD154, expression on B cells is necessary for optimal primary B cell responses. J. Immunol. 171:5707-5717.
31. Okada T, Miller MJ, Parker I, Krummel MF, Neighbors M, Hartley SB, O'Garra A, Cahalan MD, Cyster JG. 2005. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 3:e150. doi:10.1371/journal.pbio.0030150.
32. Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182:915-922.
33. Kleindienst P, Brocker T. 2005. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo. Immunology 115:556-564.
34. Macaulay AE, DeKruyff RH, Umetsu DT. 1998. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J. Immunol. 160:1694-1700.
35. Faassen AE, Dalke DP, Berton MT, Warren WD, Pierce SK. 1995. CD40-CD40 ligand interactions stimulate B cell antigen processing. Eur. J. Immunol. 25:3249-3255.
36. Evans DE, Munks MW, Purkerson JM, Parker DC. 2000. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J. Immunol. 164:688-697.
37. Conzelmann KK, Cox JH, Schneider LG, Thiel HJ. 1990. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175:485-499.
38. McGettigan JP, Naper K, Orenstein J, Koser M, McKenna PM, Schnell MJ. 2003. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirusbased vaccine vector genome. J. Virol. 77:10889-10899.
39. Gomme EA, Wirblich C, Addya S, Rall GF, Schnell MJ. 2012. Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression. PLoS Pathog. 8:e1002971. doi:10.1371/journal .ppat.1002971.
40. Quah BJ, Warren HS, Parish CR. 2007. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2:2049-2056.
41. Finke S, Conzelmann KK. 1997. Ambisense gene expression from recombinant rabies virus: random packaging of positiveand negativestrand ribonucleoprotein complexes into rabies virions. J. Virol. 71: 7281-7288.
42. Sancho D, Gomez M, Sanchez-Madrid F. 2005. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26: 136-140.
43. Barr TA, Brown S, Ryan G, Zhao J, Gray D. 2007. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37:3040-3053.
44. Robertson JM, Jensen PE, Evavold BD. 2000. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 164: 4706-4712.
45. Bachmann MF, Oxenius A. 2007. Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep. 8:1142-1148.
46. Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 6:e1001016. doi:10.1371/journal.ppat .1001016.
47. Cassell DJ, Schwartz RH. 1994. A quantitative analysis of antigenpresenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180:1829-1840.
48. Constant S, Schweitzer N, West J, Ranney P, Bottomly K. 1995. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J. Immunol. 155:3734-3741.
49. Morris SC, Lees A, Finkelman FD. 1994. In vivo activation of naive T cells by antigen-presenting B cells. J. Immunol. 152:3777-3785.
50. Lyons JA, San M, Happ MP, Cross AH. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432-3439.
51. Byersdorfer CA, Dipaolo RJ, Petzold SJ, Unanue ER. 2004. Following immunization antigen becomes concentrated in a limited number of APCs including B cells. J. Immunol. 173:6627-6634.
52. Clatza A, Bonifaz LC, Vignali DA, Moreno J. 2003. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation. J. Immunol. 171:6478-6487.
53. Xu LG, Jin L, Zhang BC, Akerlund LJ, Shu HB, Cambier JC. 2012. VISA is required for B cell expression of TLR7. J. Immunol. 188:248-258.
54. Heath E, Begue-Pastor N, Chaganti S, Croom-Carter D, Shannon-Lowe C, Kube D, Feederle R, Delecluse HJ, Rickinson AB, Bell AI. 2012. Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog. 8:e1002697. doi:10.1371/journal.ppat.1002697.
55. Rappocciolo G, Hensler HR, Jais M, Reinhart TA, Pegu A, Jenkins FJ, Rinaldo CR. 2008. Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J. Virol. 82:4793-4806.
56. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM. 2003. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J. Virol. 77:2134-2146.
57. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. 2002. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A. 99:2281-2286.
58. Valarcher JF, Bourhy H, Lavenu A, Bourges-Abella N, Roth M, Andreoletti O, Ave P, Schelcher F. 2001. Persistent infection of B lymphocytes by bovine respiratory syncytial virus. Virology 291:55-67.
59. Angel Rico M, Trento A, Ramos M, Johnstone C, Del Val M, Melero JA, Lopez D. 2009. Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes. Immunol. Cell Biol. 87:344-350.
60. Sha Z, Compans RW. 2000. Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J. Virol. 74: 4999-5005.
61. Balakrishnan A, Shahir P. 2012. Early IgM antibody response in chandipuri virus infection: T cell-independent activation of B cells. J. Clin. Cell Immunol. 3:123.
62. Belz G, Mount A, Masson F. 2009. Dendritic cells in viral infections. Handb. Exp. Pharmacol. 188:51-77.
63. Diebold SS. 2009. Activation of dendritic cells by toll-like receptors and C-type lectins. Handb. Exp. Pharmacol. 188:3-30.
64. Stein JV, Nombela-Arrieta C. 2005. Chemokine control of lymphocyte trafficking: a general overview. Immunology 116:1-12.
65. Gray D, MacLennan IC, Bazin H, Khan M. 1982. Migrant mu + delta + and static mu + delta-B lymphocyte subsets. Eur. J. Immunol. 12:564-569.
66. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529.
67. Hao Y, O'Neill P, Naradikian MS, Scholz JL, Cancro MP. 2011. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118:1294-1304.